4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Exicure, Inc. (XCUR) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 2 employees. Its market capitalization is roughly $12 million. In the fiscal year ended 2025-12-31, XCUR reported $0M in revenue and ($5M) in net income.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $29M |
| Operating Income (EBIT) | ($10M) | ($5M) | ($13M) | ($2M) |
| Net Income | ($5M) | ($10M) | ($17M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($3M) | — |
| Net Income | ($2M) | ($3M) | ($2M) | ($3M) | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $14M | $15M | $12M | $23M | — |
| Total Liabilities | $10M | $8M | $8M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XCUR viewer.
About TickerBase · Data methodology & sources